Skin tape stripping is an effective, non-invasive way to detect biomarkers associated with early disease in hidradenitis suppurativa (HS). It reveals that even normal-looking skin from HS patients is different from healthy controls.
“Diagnosis of early HS remains a major clinical challenge,” said Dr Kristina Navrazhina (Icahn School of Medicine at Mount Sinai, NY, USA) [1]. In practice, a significant diagnostic and treatment delay exists, amongst others due to a lack of biomarkers that can identify early-stage disease. Until today, biopsies are considered the gold standard for studying molecular alterations in HS skin; however, a reproducible, minimally invasive approach is needed for the diagnosis of early HS, and for longitudinal disease monitoring in trials. Therefore, Dr Navrazhina and her team explored whether skin tape strips can non-invasively detect early and late molecular alterations in HS and identify biomarkers of disease activity.
Tape strips were collected from lesional and healthy-appearing skin of HS patients (n=22) and healthy controls (n=21) and underwent RNA sequencing.
Upregulation of known HS biomarkers (e.g. IL-17, TNFα) was detected both in non-lesional and lesional skin of HS patients compared with controls. Moreover, the tape strips identified several novel therapeutic targets in lesional and non-lesional skin, including OX40, JAK3, and C-C Chemokine Receptor 4 (P<0.05 vs controls).
A significant correlation was detected between the expression of genes within the Th17 and TNFα pathways between tape strips and biopsy. Generally, there is a high variability of expression of known HS targets across HS patients, but HS clinical severity was associated with a higher expression of biomarkers in HS lesional and/or non-lesional skin. “Already Hurley stage 1 skin is different from normal skin even when it looks normal,” Dr Navrazhina commented.
The study shows that tape strips can reliably identify cutaneous biomarkers of early and late-stage HS. Thus, it could be a valid and minimally invasive way to identify patients who can benefit from early therapeutic intervention, which might be able to prevent scarring.
- Navrazhina K. Skin Tape stripping is a minimally-invasive approach that accurately detects biomarkers of early and chronic disease in hidradenitis suppurativa. D2T01.3H, EADV Congress 2023, 11–14 October, Berlin, Germany.
Copyright ©2023 Medicom Medical Publishers
Posted on
Previous Article
« Topical tapinarof – a rising star in atopic dermatitis Next Article
IL-23p19 inhibitors have a superior drug survival compared with other biologics »
« Topical tapinarof – a rising star in atopic dermatitis Next Article
IL-23p19 inhibitors have a superior drug survival compared with other biologics »
Table of Contents: EADV 2023
Featured articles
Tapinarof on course to become a new topical treatment in AD
AD and Eczema in 2023
Tapinarof on course to become a new topical treatment in AD
Upadacitinib provides sustained skin clearance in adolescents and adults with AD
Sustained deep clinical and itch responses with novel IL-13 inhibitor
IL-13 inhibitor shows potential in atopic dermatitis
Encouraging results for amlitelimab in atopic dermatitis
Chronic hand eczema: patients share similar molecular signatures regardless of AD status
Severe hand eczema: dupilumab could be a future treatment
Psoriasis News
Dual IL-17 blockade yields efficacy on joints and skin
High-dose subcutaneous spesolimab prevents GPP flares up to week 48
Drug survival of guselkumab and risankizumab seems superior to other biologics
IL-23 blockers may lower the risk of developing inflammatory and psoriatic arthritis
First-in-class oral IL-23 inhibitor safe and effective for moderate-to-severe plaque psoriasis
Hidradenitis Suppurativa: End of the Diagnostic and Therapeutic Draught
Skin tape stripping allows a novel precision medicine approach in HS
Nanobodies: A novel way to treat HS
Anti-IL17 blockade leads to maintained pain reduction in patients with HS
Vitiligo: Novel Treatment Options
JAK1 inhibition: a promising forthcoming treatment option in vitiligo
Vitiligo: Continuation of topical ruxolitinib successful in many initial non-responders
Alopecia Areata: Novel Developments
JAK3/TEC inhibition achieves clinically meaningful responses in AA
Alopecia areata: remarkable regrowth rates with deuruxolitinib
Botanical drug solution improves hair regrowth in children and adolescents with AA
What’s New in Other Disease Entities
Nemolizumab shows high success rates in prurigo nodularis
Remibrutinib reduces itch, sleep problems, and activity impairment in patients with CSU
Innovative wound gel reduces frequency of painful dressing changes in epidermolysis bullosa
Best of the Posters
Women with psoriasis face increased adverse effects with systemic therapy
Improved AI tool shows high sensitivity rates in skin cancer detection
Dermoscopy training combined with AI significantly improves skin cancer detection
Related Articles
November 25, 2020
Immuno-combination therapy in metastatic melanoma
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com